Beta
Today
Capital & Financial MarketsPortfolio & Strategy 1 Oct 2026

Gerresheimer completes Centor sale at EUR 1.50bn enterprise value

Gerresheimer completed the sale of its Centor business on 1 October 2026 at an enterprise value of EUR 1.50bn (USD 1.68bn), as part of a reorganisation of its portfolio. Adjusted EBITDA rose to EUR 102m in the second quarter of 2026 from EUR 67m in the first, on revenue of EUR 578m, below the EUR 614m of the prior-year quarter. A half-year report is due in November 2026 and a third-quarter statement in December.

Why this mattersCompletion closes a EUR 1.50bn step in Gerresheimer's portfolio reshaping, while second-quarter revenue still ran 6% below the prior year despite the EBITDA recovery.

  • Centor sale completed on 1 October 2026 at an enterprise value of EUR 1.50bn (USD 1.68bn)
  • Q2 2026 adjusted EBITDA rose to EUR 102m from EUR 67m in Q1
  • Q2 2026 revenue was EUR 578m, up from EUR 523m in Q1 but below EUR 614m a year earlier
  • Half-year financial report due in November 2026, third-quarter statement due in December 2026
Gerresheimer Centor counterparty
Sources AD HOC NEWS DE
Relevant to you?

Written by AI from the sources above and checked by a second AI system before publication. No human wrote or edited this story. How it is made.

Updates

  • 2026-10-24 · Edited before publication: The source does not support 'pharma and healthcare packaging' or call Centor a 'plastics' unit; it says only that the sale is part of a portfolio reorganisation. Removed both. Added the USD value of the enterprise value, as the publisher's note asks. Dropped the share-price bullet as colour. The sale closed on 1 October, but the source article is dated 23 October, so the